iFANN News Topic
#obesity treatment
World
Eli Lilly's Weight-Loss Pill Gets First European Approval in Britain
The MHRA authorised orforglipron for obesity and type 2 diabetes, but NHS access hinges on a NICE decision due in November.
Aug 10
World
UK regulator approves Lilly's weight-loss pill
The MHRA clearance for orforglipron, branded Foundayo, covers both obesity and type 2 diabetes and sets up a direct clash with Novo Nordisk’s oral semaglutide in Britain.
Aug 10